Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.

about

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.

Item

http://www.wikidata.org/entity/Q49578631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Testing the mutant selection w ...... in an in vitro dynamic model.

@en

Testing the mutant selection w ...... in an in vitro dynamic model.

@nl

type

Item

label

Testing the mutant selection w ...... in an in vitro dynamic model.

@en

Testing the mutant selection w ...... in an in vitro dynamic model.

@nl

prefLabel

Testing the mutant selection w ...... in an in vitro dynamic model.

@en

Testing the mutant selection w ...... in an in vitro dynamic model.

@nl

P1476

Testing the mutant selection w ...... d in an in vitro dynamic model

@en

P2093

Alexander A Firsov

http://www.w3.org/2001/XMLSchema#string

Andrey V Romanov

http://www.w3.org/2001/XMLSchema#string

Kamilla N Alieva

http://www.w3.org/2001/XMLSchema#string

Maria V Golikova

http://www.w3.org/2001/XMLSchema#string

Mikhail B Kobrin

http://www.w3.org/2001/XMLSchema#string

Mikhail V Edelstein

http://www.w3.org/2001/XMLSchema#string

Stephen H Zinner

http://www.w3.org/2001/XMLSchema#string

Svetlana A Dovzhenko

http://www.w3.org/2001/XMLSchema#string

P2860

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.

Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.

Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus

Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection

In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.

Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

P304

3100-3107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX249

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena N. Strukova

Y A Portnoy

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28981793

http://www.w3.org/2001/XMLSchema#string